Mark J. Holdbrook, V.P, Clinical Affairs at Tarsus Pharmaceuticals, Inc. (TARS), sold 386 shares at $12.61 ($5K) on 2023-03-20, disclosed to the SEC on 2023-03-21.
Open-market sale of $5k TARS by V.P, Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.28 | 188 | $2K | 50.0% |
| 2 | $12.61 | 198 | $2K | 50.0% |
| Total | $12.94 avg | 386 | $5K | 100% |